Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

SUPPORT Aktie 136367563 / JP3322820006

07.11.2025 06:06:01

Bitcoin At Increased Risk Of Falling To $88,500 Support, Glassnode Warns

On-chain analytics firm Glassnode has revealed how Bitcoin could be at risk of a further drawdown after trading at a significant discount to a key cost basis level.Bitcoin Could Retest Active Realized Price NextIn its latest weekly report, Glassnode has talked about how Bitcoin has dropped a notable distance below the short-term holder (STH) Realized Price. The “Realized Price” here refers to an on-chain metric that tracks the cost basis of the average investor or address on the BTC network.To any investor, their break-even mark tends to be a level of particular importance, as retests of it can potentially flip their profit-loss situation. Due to this, Realized Price levels have often shown interactions with the asset’s price, as investors make moves to either exit with their money back or buy more to defend their cost basis.A group that’s considered particularly sensitive to short-term volatility is the STH cohort, made up of the investors who purchased their coins within the past 155 days.The Realized Price of the STHs generally provides support during bullish trends, but with the recent market crash, Bitcoin has plummeted under it.As displayed in the above chart, Bitcoin at its post-crash levels is trading significantly below the STH Realized Price located at $112,500. This means that members of the cohort are now notably underwater.“Historically, discounts with such depth from this level have increased the likelihood of further downside toward lower structural supports,” explained Glassnode. One such support is the Active Realized Price, corresponding to the cost basis of the “economically active” part of the BTC supply.A chunk of the cryptocurrency’s supply has been dormant for so long that it can safely be presumed lost. In other words, these tokens will never make their way back into circulation. Such coins have no effect on the market today, so the Active Realized Price excludes them from the data, labeling them “economically inactive.”The report noted that this level “has often served as a critical reference point during extended corrective phases in prior cycles.” At present, the indicator is sitting near $88,500.The Bitcoin STH Realized Price isn’t the only level that the asset has lost recently. As on-chain analytics firm CryptoQuant has pointed out in an X post, the asset has also declined below the 365-day moving average (MA).CryptoQuant has described the line as “a key technical and psychological support level last broken at the start of the 2022 bear market.” Considering that Bitcoin has lost the STH Realized Price, and now, this level as well, it remains to be seen whether the asset will end up retesting the Active Realized Price and other lower support levels.BTC PriceAt the time of writing, Bitcoin is floating around $103,300, down over 6% in the last seven days.Weiter zum vollständigen Artikel bei NewsBTC

Analysen zu SUPPORT Co.,Ltd. Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’811.85 19.22 S2S3YU
Short 13’049.67 13.98 B7ZS2U
Short 13’568.01 8.78 UJOBSU
SMI-Kurs: 12’258.92 07.11.2025 11:33:29
Long 11’805.71 20.00 SQBBAU
Long 11’517.06 13.67 BIYSFU
Long 11’017.53 8.85 BSXSZU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com